- 专利标题： PYRIMIDINONES AS PI3K INHIBITORS
-
申请号： US17038165申请日： 2020-09-30
-
公开(公告)号： US20210253601A1公开(公告)日： 2021-08-19
- 发明人: Yun-Long Li , Brian W. Metcalf , Andrew P. Combs
- 申请人： Incyte Corporation , Incyte Holdings Corporation
- 申请人地址： US DE Wilmington; US DE Wilmington
- 专利权人： Incyte Corporation,Incyte Holdings Corporation
- 当前专利权人： Incyte Corporation,Incyte Holdings Corporation
- 当前专利权人地址： US DE Wilmington; US DE Wilmington
- 主分类号： C07D519/00
- IPC分类号： C07D519/00 ; C07D471/04 ; C07D513/04 ; C07D487/04
摘要：
The present invention provides pyrimidinones that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
信息查询
